Small molecules still represent the lion's share of the pharmaceutical market, despite the rise in importance of biologics in recent years. But the nature of many of these compounds is changing, with many now posing challenges in the manufacturing plant and in formulation. This eBook will look at some of those challenges, and what can be done to address them.
Content Type: eBook
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center